Significance of IgM anti-HCV in chronic hepatitis C patients-treated by daily interferon regimen

F. Zara; M. Debiaggi; R. Bruno; E. Maffezzini; A. Pistorio; R. Brerra; M. G. Ferrari; E. Fasani; E. Romero; G. Filice

Significance of IgM anti-HCV in chronic hepatitis C patients-treated by daily interferon regimen

F. Zara, M. Debiaggi, R. Bruno, E. Maffezzini, A. Pistorio, R. Brerra, M. G. Ferrari, E. Fasani, E. Romero, G. Filice

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: To assess if detection of IgM anti-HCV is correlated with HCV-replication, genotype, histological activity and effects of daily α-IFN regimen on HCV production. Patients and methods: We evaluated serum biochemical and virological profiles and liver histology in a cohort of 22 patients with chronic hepatitis C treated with 3 mega units of IFN α-2a daily/dose for at least 12 months. Results: All 22 patients with chronic hepatitis C had HCV IgG antibodies. IgM anti-HCV were detected in 15 cases (68.1%). All 22 patients were HCV-RNA positive; although mean HCV-RNA titers were higher in IgM positive than IgM negative patients, they did not differ significantly. At month 18 a sustained biochemical and virological response was observed in 7/22 (31.8%) and was more frequent in IgM negative than IgM positive patients (p=0.08 and p

Original language	English
Pages (from-to)	144-148
Number of pages	5
Journal	Giornale Italiano di Malattie Infettive
Volume	6
Issue number	3
Publication status	Published - 2000

Keywords

Chronic hepatitis
Daily interferon regimen
IgM anti-HCV

ASJC Scopus subject areas

Microbiology (medical)

Cite this

@article{08f66ebbc1034fe8990b8d6a123a4766,

title = "Significance of IgM anti-HCV in chronic hepatitis C patients-treated by daily interferon regimen",

abstract = "Objectives: To assess if detection of IgM anti-HCV is correlated with HCV-replication, genotype, histological activity and effects of daily α-IFN regimen on HCV production. Patients and methods: We evaluated serum biochemical and virological profiles and liver histology in a cohort of 22 patients with chronic hepatitis C treated with 3 mega units of IFN α-2a daily/dose for at least 12 months. Results: All 22 patients with chronic hepatitis C had HCV IgG antibodies. IgM anti-HCV were detected in 15 cases (68.1%). All 22 patients were HCV-RNA positive; although mean HCV-RNA titers were higher in IgM positive than IgM negative patients, they did not differ significantly. At month 18 a sustained biochemical and virological response was observed in 7/22 (31.8%) and was more frequent in IgM negative than IgM positive patients (p=0.08 and p",

keywords = "Chronic hepatitis, Daily interferon regimen, IgM anti-HCV",

author = "F. Zara and M. Debiaggi and R. Bruno and E. Maffezzini and A. Pistorio and R. Brerra and Ferrari, {M. G.} and E. Fasani and E. Romero and G. Filice",

year = "2000",

language = "English",

volume = "6",

pages = "144--148",

journal = "Giornale Italiano di Malattie Infettive",

issn = "1126-9952",

publisher = "U T E T SpA",

number = "3",

}

TY - JOUR

T1 - Significance of IgM anti-HCV in chronic hepatitis C patients-treated by daily interferon regimen

AU - Zara, F.

AU - Debiaggi, M.

AU - Bruno, R.

AU - Maffezzini, E.

AU - Pistorio, A.

AU - Brerra, R.

AU - Ferrari, M. G.

AU - Fasani, E.

AU - Romero, E.

AU - Filice, G.

PY - 2000

Y1 - 2000

N2 - Objectives: To assess if detection of IgM anti-HCV is correlated with HCV-replication, genotype, histological activity and effects of daily α-IFN regimen on HCV production. Patients and methods: We evaluated serum biochemical and virological profiles and liver histology in a cohort of 22 patients with chronic hepatitis C treated with 3 mega units of IFN α-2a daily/dose for at least 12 months. Results: All 22 patients with chronic hepatitis C had HCV IgG antibodies. IgM anti-HCV were detected in 15 cases (68.1%). All 22 patients were HCV-RNA positive; although mean HCV-RNA titers were higher in IgM positive than IgM negative patients, they did not differ significantly. At month 18 a sustained biochemical and virological response was observed in 7/22 (31.8%) and was more frequent in IgM negative than IgM positive patients (p=0.08 and p

AB - Objectives: To assess if detection of IgM anti-HCV is correlated with HCV-replication, genotype, histological activity and effects of daily α-IFN regimen on HCV production. Patients and methods: We evaluated serum biochemical and virological profiles and liver histology in a cohort of 22 patients with chronic hepatitis C treated with 3 mega units of IFN α-2a daily/dose for at least 12 months. Results: All 22 patients with chronic hepatitis C had HCV IgG antibodies. IgM anti-HCV were detected in 15 cases (68.1%). All 22 patients were HCV-RNA positive; although mean HCV-RNA titers were higher in IgM positive than IgM negative patients, they did not differ significantly. At month 18 a sustained biochemical and virological response was observed in 7/22 (31.8%) and was more frequent in IgM negative than IgM positive patients (p=0.08 and p

KW - Chronic hepatitis

KW - Daily interferon regimen

KW - IgM anti-HCV

UR - http://www.scopus.com/inward/record.url?scp=0034461031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034461031&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034461031

VL - 6

SP - 144

EP - 148

JO - Giornale Italiano di Malattie Infettive

JF - Giornale Italiano di Malattie Infettive

SN - 1126-9952

IS - 3

ER -

Significance of IgM anti-HCV in chronic hepatitis C patients-treated by daily interferon regimen

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this